COCP
COCP
NASDAQ · Pharmaceuticals

Cocrystal Pharma Inc

$1.04
+0.04 (+4.00%)
As of Nov 7, 2:46 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,584.6% upside
Low Target $19.61
Average Target $27.92
High Target $38.36
Current Price $1.04
Current
$1.04
Target
$27.92
$19.61 $27.92 avg $38.36
Scenario Analysis
Bear Case
$19.61
1,785.6%
Low target
Base Case
$27.92
+2,584.6%
Avg target
Bull Case
$38.36
+3,588.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.03
-48.8% from high
52-Week Low
$0.76
+36.8% from low
Target vs 52W High
$27.92
+1,275.4% vs high
Next Earnings Report
Nov 12, 2026
4d
until earnings
EPS Est: $-0.18
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%